[1] |
樊翌明, 李顺凡, 吴志华. Ehlers⁃Danlos综合征一例[J]. 中华皮肤科杂志, 2002,35(3):247.
|
[2] |
Lavanya K, Mahtani K, Abbott J, et al. A patient with a novel pathogenic variant in COL5A1 exhibiting prominent vascular and cardiac features[J]. Am J Med Genet A, 2022,188(7):2192⁃2197. doi: 10.1002/ajmg.a.62745.
|
[3] |
Colombi M, Dordoni C, Venturini M, et al. Delineation of Ehlers⁃Danlos syndrome phenotype due to the c.934C>T, p.(Arg312Cys) mutation in COL1A1: report on a three⁃generation family without cardiovascular events, and literature review[J]. Am J Med Genet A, 2017,173(2):524⁃530. doi: 10.1002/ajmg.a. 38035.
|
[4] |
Duong J, Rideout A, MacKay S, et al. A family with classical Ehlers⁃Danlos syndrome (cEDS), mild bone fragility and without vascular complications, caused by the p.Arg312Cys mutation in COL1A1[J]. Eur J Med Genet, 2020,63(2):103730. doi: 10.1016/j.ejmg.2019.103730.
|
[5] |
Joseph AW, Joseph SS, Francomano CA, et al. Characteristics, diagnosis, and management of Ehlers⁃Danlos syndromes: a review[J]. JAMA Facial Plast Surg, 2018,20(1):70⁃75. doi: 10.1001/jamafacial.2017.0793.
|
[6] |
Colombi M, Dordoni C, Cinquina V, et al. A classical Ehlers⁃Danlos syndrome family with incomplete presentation diagnosed by molecular testing[J]. Eur J Med Genet, 2018,61(1):17⁃20. doi: 10.1016/j.ejmg.2017.10.005.
|
[7] |
Kling S, Torres⁃Netto EA, Abdshahzadeh H, et al. Collagen V insufficiency in a mouse model for Ehlers Danlos⁃syndrome affects viscoelastic biomechanical properties explaining thin and brittle corneas[J]. Sci Rep, 2021,11(1):17362. doi: 10.1038/s41598⁃021⁃96775⁃w.
|
[8] |
杨月, 冒丹丹, 贾园, 等. COL5A1基因新突变导致的经典型Ehlers⁃Danlos综合征一例[J]. 中华风湿病学杂志, 2018,22(1):44⁃45. doi: 10.3760/cma.j.issn.1007⁃7480.2018.01.014.
|
[9] |
Gong Z, Wang H, Lin Z. Glycine substitution mutation of COL5A1 in classic Ehlers⁃Danlos syndrome: a case report and literature review[J]. Clin Exp Dermatol, 2021,46(5):987⁃989. doi: 10.1111/ced.14568.
|
[10] |
Malfait F, Wenstrup RJ, De Paepe A. Clinical and genetic aspects of Ehlers⁃Danlos syndrome, classic type[J]. Genet Med, 2010,12(10):597⁃605. doi: 10.1097/GIM.0b013e3181eed412.
|
[11] |
Colman M, Syx D, De Wandele I, et al. Clinical and molecular characteristics of 168 probands and 65 relatives with a clinical presentation of classical Ehlers⁃Danlos syndrome[J]. Hum Mutat, 2021,42(10):1294⁃1306. doi: 10.1002/humu.24258.
|
[12] |
Bowen JM, Sobey GJ, Burrows NP, et al. Ehlers⁃Danlos syndrome, classical type[J]. Am J Med Genet C Semin Med Genet, 2017,175(1):27⁃39. doi: 10.1002/ajmg.c.31548.
|
[13] |
Beighton P, De Paepe A, Steinmann B, et al. Ehlers⁃Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers⁃Danlos National Foundation (USA) and Ehlers⁃Danlos Support Group (UK)[J]. Am J Med Genet, 1998,77(1):31⁃37. doi: 10.1002/(sici)1096⁃8628(19980428)77:13.0.co;2⁃o.
|
[14] |
Colman M, Castori M, Micale L, et al. Atypical variants in COL1A1 and COL3A1 associated with classical and vascular Ehlers⁃Danlos syndrome overlap phenotypes: expanding the clinical phenotype based on additional case reports[J]. Clin Exp Rheumatol, 2022,40 Suppl 134(5):46⁃62. doi: 10.55563/clinexprheumatol/kzkq6y.
|
[15] |
Santoreneos R, Vakulin C, Ellul M, et al. Recurrent pneumothorax in a case of tenascin⁃X deficient Ehlers⁃Danlos syndrome: broadening the phenotypic spectrum[J]. Am J Med Genet A, 2022,188(5):1583⁃1588. doi: 10.1002/ajmg.a.62674.
|
[16] |
Sobey G. Ehlers⁃Danlos syndrome: how to diagnose and when to perform genetic tests[J]. Arch Dis Child, 2015,100(1):57⁃61. doi: 10.1136/archdischild⁃2013⁃304822.
|
[17] |
Kaufman CS, Butler MG. Mutation in TNXB gene causes moderate to severe Ehlers⁃Danlos syndrome[J]. World J Med Genet, 2016,6(2):17⁃21. doi: 10.5496/wjmg.v6.i2.17.
|
[18] |
Green C, Ghali N, Akilapa R, et al. Classical⁃like Ehlers⁃Danlos syndrome: a clinical description of 20 newly identified individuals with evidence of tissue fragility[J]. Genet Med, 2020,22(10):1576⁃1582. doi: 10.1038/s41436⁃020⁃0850⁃1.
|
[19] |
Shalhub S, Black JH 3rd, Cecchi AC, et al. Molecular diagnosis in vascular Ehlers⁃Danlos syndrome predicts pattern of arterial involvement and outcomes[J]. J Vasc Surg, 2014,60(1):160⁃169. doi: 10.1016/j.jvs.2014.01.070.
|
[20] |
Bilousova G. Gene therapy for skin fragility diseases: the new generation[J]. J Invest Dermatol, 2019,139(8):1634⁃1637. doi: 10.1016/j.jid.2019.04.001.
|